Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Total Liabilities 2014–2025
Akebia Therapeutics Inc. annual total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Akebia Therapeutics Inc. total liabilities as of December 31, 2025: 344.0M, a 27.46% increase year-over-year.
- Akebia Therapeutics Inc. total liabilities for 2025 were 344.0M, a 27.46% increase from 2024.
- Akebia Therapeutics Inc. total liabilities for 2024 were 269.9M, a 0.89% decrease from 2023.
- Akebia Therapeutics Inc. total liabilities for 2023 were 272.3M, a 22.39% decrease from 2022.
- Akebia Therapeutics Inc. total liabilities for 2022 were 350.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Akebia Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $344 |
| 2024 | $270 |
| 2023 | $272 |
| 2022 | $351 |
| 2021 | $455 |
| 2020 | $397 |
| 2019 | $376 |
| 2018 | $361 |
| 2017 | $242 |
| 2016 | $232 |
| 2015 | $12 |
| 2014 | $7 |
Akebia Therapeutics Inc. Total Liabilities — FAQ
Akebia Therapeutics Inc. (AKBA) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AKBA's total liabilities history?
The chart and table above show Akebia Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.